Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EMR | Common Stock | Award | +28.3K | +12.21% | 260K | Nov 6, 2023 | Direct | F1, F2 | ||
transaction | EMR | Common Stock | Award | +9.74K | +3.75% | 270K | Nov 6, 2023 | Direct | F3, F4 | ||
holding | EMR | Common Stock | 828 | Nov 6, 2023 | Profit Sharing Plan | ||||||
holding | EMR | Common Stock | 11.3K | Nov 6, 2023 | 401(k) plan | ||||||
holding | EMR | Common Stock | 1.32K | Nov 6, 2023 | 401(k) excess plan |
Id | Content |
---|---|
F1 | Acquisition of 28,305 shares pursuant to Rule 16b-3 upon payout of 51,465 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2023. Of these 51,465 units, 28,305 units were paid in shares of Issuer stock, with the remaining 23,160 units paid in cash to cover the reporting person's tax obligations. |
F2 | Price is not applicable to the acquisitions described in Note 1. |
F3 | Grant to Reporting Person of 9,744 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
F4 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |